Wilmington Savings Fund Society FSB Invests $24.69 Million in Doximity, Inc. (NASDAQ:DOCS)

Wilmington Savings Fund Society FSB bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 566,700 shares of the company's stock, valued at approximately $24,691,000. Wilmington Savings Fund Society FSB owned 0.30% of Doximity at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Farther Finance Advisors LLC boosted its stake in Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after buying an additional 603 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Doximity by 621.4% during the 2nd quarter. Blue Trust Inc. now owns 1,385 shares of the company's stock valued at $37,000 after purchasing an additional 1,193 shares in the last quarter. Quarry LP boosted its position in shares of Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company's stock valued at $45,000 after purchasing an additional 131,253 shares in the last quarter. Morse Asset Management Inc acquired a new position in shares of Doximity in the 3rd quarter worth approximately $46,000. Finally, First Horizon Advisors Inc. raised its holdings in shares of Doximity by 80.0% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company's stock worth $48,000 after purchasing an additional 760 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of research reports. Evercore ISI raised their target price on shares of Doximity from $34.00 to $45.00 and gave the stock an "in-line" rating in a report on Tuesday, October 8th. Canaccord Genuity Group lowered Doximity from a "buy" rating to a "hold" rating and raised their price objective for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. Robert W. Baird boosted their target price on Doximity from $41.00 to $45.00 and gave the stock an "outperform" rating in a research report on Tuesday, September 17th. Raymond James reiterated an "outperform" rating and issued a $65.00 price target (up previously from $37.00) on shares of Doximity in a research report on Friday, November 8th. Finally, Mizuho assumed coverage on Doximity in a report on Wednesday, December 4th. They set a "neutral" rating and a $55.00 price objective on the stock. Twelve investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Doximity currently has an average rating of "Hold" and a consensus target price of $52.44.

Doximity Stock Up 0.3 %

Shares of NASDAQ:DOCS traded up $0.16 during trading on Thursday, reaching $52.70. The stock had a trading volume of 1,390,693 shares, compared to its average volume of 1,751,743. The stock has a fifty day simple moving average of $47.69 and a two-hundred day simple moving average of $37.60. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The firm has a market capitalization of $9.84 billion, a price-to-earnings ratio of 60.57, a P/E/G ratio of 4.45 and a beta of 1.39.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.